We are live on ! Find out more
BOCH

Blue Owl Capital Holdings Portfolio holdings

AUM $372M
1-Year Est. Return 78.25%
This Fund
S&P 500
This Quarter Est. Return
-13.36%
1 Year Est. Return
+78.25%
3 Year Est. Return
+112.77%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$360M
AUM Growth
-$141M
Cap. Flow
-$61.4M
Cap. Flow %
-17.07%
Top 10 Hldgs %
67.99%
Holding
55
New
10
Increased
7
Reduced
8
Closed
14

Top Buys

Rank Stock Value
1
CNTX icon
Context Therapeutics
CNTX
+$8.9M
2
VKTX icon
Viking Therapeutics
VKTX
+$6.23M
3
DM
Desktop Metal, Inc.
DM
+$4.62M
4
STWD icon
Starwood Property Trust
STWD
+$4.41M
5
PYXS icon
Pyxis Oncology
PYXS
+$4.4M

Top Sells

Rank Stock Value
1
HOOD icon
Robinhood
HOOD
+$54M
2
CGEM icon
Cullinan Oncology
CGEM
+$18.6M
3
MLTX icon
MoonLake Immunotherapeutics
MLTX
+$5.02M
4
DELL icon
Dell
DELL
+$4.71M
5
LABD icon
Direxion Daily S&P Biotech Bear 3X ETF
LABD
+$3.57M

Sector Composition

Rank Sector Weight
1 Healthcare 71.57%
2 Technology 17.92%
3 Financials 8.96%
4 Real Estate 1.19%
5 Industrials 0.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OVID icon
51
Ovid Therapeutics
OVID
$491M
– –
-864,822
Closed -$2.64M
RLYB icon
52
Rallybio
RLYB
$85.8M
– –
-43,780
Closed -$648K
SNOW icon
53
Snowflake
SNOW
$115B
– –
-7,819
Closed -$1.26M
UBER icon
54
Uber
UBER
$153B
– –
-23,918
Closed -$78.9K
FATH
55
DELISTED
Fathom Digital Manufacturing Corporation
FATH
– –
-50,000
Closed -$231K
1 2
3

Similar funds

PC
Promethos Capital Boston, Massachusetts $372M AUM 23.19% 1-Year Est. Return
GIP
Gavilan Investment Partners Burlingame, California $372M AUM 6.04% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
SAAM
Solus Alternative Asset Management Summit, New Jersey $372M AUM 45.33% 1-Year Est. Return
KP
Kiltearn Partners Edinburgh, United Kingdom $372M AUM 18.16% 1-Year Est. Return
TCM
Thomist Capital Management Houston, Texas $371M AUM 77.62% 1-Year Est. Return
PAA
Peregrine Asset Advisers Portland, Oregon $371M AUM 41.36% 1-Year Est. Return
JC
Joho Capital New York $373M AUM 18.89% 1-Year Est. Return

Blue Owl Capital Holdings's Q2 2024 Portfolio in Review

As of Q2 2024, Blue Owl Capital Holdings held 55 positions worth $360M, down 28% from $501M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Blue Owl Capital Holdings withdrew a net $61.4M in Q2 2024, closing 14 positions and reducing 8 holdings. Its most notable exit was Robinhood, an estimated $54M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 72% of assets, up from 67% a quarter earlier, followed by Technology and Financials.

Against the trend, Blue Owl Capital Holdings opened a new position in Context Therapeutics worth $10.3M.

  • Blue Owl Capital Holdings's largest Q2 2024 buy was Context Therapeutics: 5,161,290 shares worth $10.3M.
  • Blue Owl Capital Holdings added most to Desktop Metal, Inc. in Q2 2024, an estimated $4.62M increase.
  • Blue Owl Capital Holdings's biggest Q2 2024 reduction was Cullinan Oncology, cutting an estimated $18.6M.
  • Blue Owl Capital Holdings fully exited Robinhood in Q2 2024, selling an estimated $54M.
  • Blue Owl Capital Holdings's ten largest holdings make up 68% of its $360M portfolio in Q2 2024.
  • Blue Owl Capital Holdings opened 10 new positions and closed 14 in Q2 2024.
  • Blue Owl Capital Holdings's portfolio value fell 28% quarter-over-quarter to $360M.

Based on Blue Owl Capital Holdings's 13F filing for Q2 2024, filed 15 Aug 2024.